Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer
Bai-Cheng He,Jian-Li Gao,Bing-Qiang Zhang,Qing Luo,Qiong Shi,Stephanie H. Kim,Enyi Huang,Yanhong Gao,Ke Yang,Eric R. Wagner,Linyuan Wang,Ni Tang,Jinyong Luo,Xing Liu,Mi Li,Yang Bi,Jikun Shen,Gaurav Luther,Ning Hu,Qixin Zhou,Hue H. Luu,Rex C. Haydon,Yingming Zhao,Tong-Chuan He
DOI: https://doi.org/10.1124/mol.110.068668
2011-01-01
Molecular Pharmacology
Abstract:As one of the most common malignancies, colon cancer is initiated by abnormal activation of the Wnt/beta-catenin pathway. Although the treatment options have increased for some patients, overall progress has been modest. Thus, there is a great need to develop new treatments. We have found that bisbenzylisoquinoline alkaloid tetrandrine (TET) exhibits anticancer activity. TET is used as a calcium channel blocker to treat hypertensive and arrhythmic conditions in Chinese medicine. Here, we investigate the molecular basis underlying TET's anticancer activity. We compare TET with six chemotherapy drugs in eight cancer lines and find that TET exhibits comparable anticancer activities with camptothecin, vincristine, paclitaxel, and doxorubicin, and better than that of 5-fluorouracil (5-FU) and carboplatin. TET IC50 is <5 mu M in most of the tested cancer lines. TET exhibits synergistic anticancer activity with 5-FU and reduces migration and invasion capabilities of HCT116 cells. Furthermore, TET induces apoptosis and inhibits xenograft tumor growth of colon cancer. TET treatment leads to a decrease in beta-catenin protein level in xenograft tumors, which is confirmed by T-cell factor/lymphocyte enhancer factor and c-Myc reporter assays. It is noteworthy that HCT116 cells with allelic oncogenic beta-catenin deleted are less sensitive to TET-mediated inhibition of proliferation, viability, and xenograft tumor growth. Thus, our findings strongly suggest that the anticancer effect of TET in colon cancer may be at least in part mediated by targeting beta-catenin activity. Therefore, TET may be used alone or in combination as an effective anticancer agent.